Breaking News

FUJIFILM Diosynth Expands Gene Therapy Mfg. Capacity

The $35 million capacity expansion at College Station, TX will add cell culture and high throughput manufacturing suites

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Diosynth Biotechnologies U.S.A., Inc. (FDB), a cGMP Contract Development and Manufacturing Organization supporting the development and manufacture of biologics, vaccines and gene therapies, began the $35 million capacity expansion of its Flexible Biomanufacturing Facility at its College Station, TX location. The facility is designed to support late phase and commercial manufacturing of gene therapies and other advanced therapies. The Flexible Biomanufacturing Facility complements the ea...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters